Fatigability, Exercise Intolerance, and Abnormal Skeletal Muscle Energetics in Heart Failure

Circulation: Heart Failure

Volumn 10, Issue 7, 2017, Pages

  Weiss, Kilian ^a,b,c   Schär, Michael ^b   Panjrath, Gurusher S ^a,d   Zhang, Yi ^f   Sharma, Kavita ^a   Bottomley, Paul A ^b   Golozar, Asieh ^e   Steinberg, Angela ^a   Gerstenblith, Gary ^a   Russell, Stuart D ^a   Weiss, Robert G ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PHILIPS HEALTHCARE   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f NONE

Author keywords

magnetic resonance imaging; magnetic resonance spectroscopy; skeletal muscle

Indexed keywords

CREATINE KINASE; CREATINE PHOSPHATE; ADENOSINE TRIPHOSPHATE;

ADULT; ARTICLE; BICYCLE ERGOMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; EXERCISE; FATIGUE; FEMALE; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HIGH ENERGY PHOSPHATE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLASTICITY; PRIORITY JOURNAL; SKELETAL MUSCLE; EXERCISE TOLERANCE; METABOLISM; MIDDLE AGED; MUSCLE FATIGUE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; ADULT; ENERGY METABOLISM; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUSCLE FATIGUE; MUSCLE, SKELETAL; OXYGEN CONSUMPTION;

EID: 85024890219     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.117.004129     Document Type: Article

References (43)

1. Piña IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, Fletcher BJ, Fleg JL, Myers JN, Sullivan MJ; American Heart Association Committee on Exercise, Rehabilitation, and Prevention. Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation. 2003;107:1210-1225.
2. Stevenson LW, Sietsema K, Tillisch JH, Lem V, Walden J, Kobashigawa JA, Moriguchi J. Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure. Circulation. 1990;81:78-85.
3. Haykowsky MJ, Brubaker PH, Stewart KP, Morgan TM, Eggebeen J, Kitzman DW. Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction. J Am Coll Cardiol. 2012;60:120-128. doi: 10.1016/j.jacc.2012.02.055.
4. Kao AC, Van Trigt P 3rd, Shaeffer-McCall GS, Shaw JP, Kuzil BB, Page RD, Higginbotham MB. Central and peripheral limitations to upright exercise in untrained cardiac transplant recipients. Circulation. 1994;89:2605-2615.
5. Eldadah BA. Fatigue and fatigability in older adults. PM R. 2010;2:406-413. doi: 10.1016/j.pmrj.2010.03.022.
6. Allen DG, Lamb GD, Westerblad H. Skeletal muscle fatigue: cellular mechanisms. Physiol Rev. 2008;88:287-332. doi: 10.1152/physrev.00015.2007.
7. Radda GK. The use of NMR spectroscopy for the understanding of disease. Science. 1986;233:640-645.
8. Das AM, Steuerwald U, Illsinger S. Inborn errors of energy metabolism associated with myopathies. J Biomed Biotechnol. 2010;2010:340849. doi: 10.1155/2010/340849.
9. Wortmann RL. Metabolic myopathies. Curr Opin Rheumatol. 1991;3: 925-933.
10. Barnes PR, Kemp GJ, Taylor DJ, Radda GK. Skeletal muscle metabolism in myotonic dystrophy A 31P magnetic resonance spectroscopy study. Brain. 1997;120(pt 10):1699-1711.
11. Younkin DP, Berman P, Sladky J, Chee C, Bank W, Chance B. 31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes. Neurology. 1987;37:165-169.
12. Massie B, Conway M, Yonge R, Frostick S, Ledingham J, Sleight P, Radda G, Rajagopalan B. Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation. 1987;76:1009-1019.
13. Wiener DH, Fink LI, Maris J, Jones RA, Chance B, Wilson JR. Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation. 1986;73:1127-1136.
14. Mancini DM, Coyle E, Coggan A, Beltz J, Ferraro N, Montain S, Wilson JR. Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation. 1989;80:1338-1346.
15. Marie PY, Escanye JM, Brunotte F, Robin B, Walker P, Zannad F, Robert J, Gilgenkrantz JM. Skeletal muscle metabolism in the leg during exercise in patients with congestive heart failure. Clin Sci (Lond). 1990;78:515-519.
16. Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation. 1992;85:1364-1373.
17. Nakae I, Mitsunami K, Matsuo S, Inubushi T, Morikawa S, Koh T, Horie M. Detection of calf muscle alterations in patients with chronic heart failure by P magnetic resonance spectroscopy: Impaired adaptation to continuous exercise. Exp Clin Cardiol. 2005;10:4-8.
18. Molina AJ, Bharadwaj MS, Van Horn C, Nicklas BJ, Lyles MF, Eggebeen J, Haykowsky MJ, Brubaker PH, Kitzman DW. Skeletal muscle mitochondrial content, oxidative capacity, and Mfn2 expression are reduced in older patients with heart failure and preserved ejection fraction and are related to exercise intolerance. JACC Heart Fail. 2016;4:636-645. doi: 10.1016/j.jchf.2016.03.011.
19. Kitzman DW, Nicklas B, Kraus WE, Lyles MF, Eggebeen J, Morgan TM, Haykowsky M. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2014;306:H1364-H1370. doi: 10.1152/ajpheart.00004.2014.
20. Haykowsky MJ, Kouba EJ, Brubaker PH, Nicklas BJ, Eggebeen J, Kitzman DW. Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Cardiol. 2014;113:1211-1216. doi: 10.1016/j.amjcard.2013.12.031.
21. Bowen TS, Rolim NP, Fischer T, Baekkerud FH, Medeiros A, Werner S, Brønstad E, Rognmo O, Mangner N, Linke A, Schuler G, Silva GJ, Wisløff U, Adams V; Optimex Study Group. Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle. Eur J Heart Fail. 2015;17:263-272. doi: 10.1002/ejhf.239.
22. Bhella PS, Prasad A, Heinicke K, Hastings JL, Arbab-Zadeh A, Adams-Huet B, Pacini EL, Shibata S, Palmer MD, Newcomer BR, Levine BD. Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. Eur J Heart Fail. 2011;13:1296-1304. doi: 10.1093/eurjhf/hfr133.
23. Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC, Kass DA. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation. 2006;114:2138-2147. doi: 10.1161/CIRCULATIONAHA.106.632745.
24. Lanza IR, Bhagra S, Nair KS, Port JD. Measurement of human skeletal muscle oxidative capacity by 31P-MR spectroscopy: a cross-validation with in vitro measurements. J Magn Reson Imaging. 2011;34:1143-1150. doi: 10.1002/jmri.22733.
25. Goldberg IJ, Trent CM, Schulze PC. Lipid metabolism and toxicity in the heart. Cell Metab. 2012;15:805-812. doi: 10.1016/j.cmet.2012.04.006.
26. Bottomley PA, Panjrath GS, Lai S, Hirsch GA, Wu K, Najjar SS, Steinberg A, Gerstenblith G, Weiss RG. Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death. Sci Transl Med. 2013;5:215re3. doi: 10.1126/scitranslmed.3007328.
27. Kemp GJ, Thompson CH, Stratton JR, Brunotte F, Conway M, Adamopoulos S, Arnolda L, Radda GK, Rajagopalan B. Abnormalities in exercising skeletal muscle in congestive heart failure can be explained in terms of decreased mitochondrial ATP synthesis, reduced metabolic efficiency, and increased glycogenolysis. Heart. 1996;76:35-41.
28. Drexler H, Riede U, Münzel T, König H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation. 1992;85:1751-1759.
29. Cohen-Solal A, Laperche T, Morvan D, Geneves M, Caviezel B, Gourgon R. Prolonged kinetics of recovery of oxygen consumption after maximal graded exercise in patients with chronic heart failure. Analysis with gas exchange measurements and NMR spectroscopy. Circulation. 1995;91:2924-2932.
30. Zelis R, Mason DT, Braunwald E. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest. 1968;47:960-970. doi: 10.1172/JCI105788.
31. Zelis R, Longhurst J, Capone RJ, Mason DT. A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure. Circulation. 1974;50:137-143.
32. Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation. 1989;80:769-781.
33. Wilson JR, Fink L, Maris J, Ferraro N, Power-Vanwart J, Eleff S, Chance B. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation. 1985;71:57-62.
34. Mancini DM, Wilson JR, Bolinger L, Li H, Kendrick K, Chance B, Leigh JS. In vivo magnetic resonance spectroscopy measurement of deoxymyoglobin during exercise in patients with heart failure. Demonstration of abnormal muscle metabolism despite adequate oxygenation. Circulation. 1994;90:500-508.
35. Nilsson KR, Duscha BD, Hranitzky PM, Kraus WE. Chronic heart failure and exercise intolerance: the hemodynamic paradox. Curr Cardiol Rev. 2008;4:92-100. doi: 10.2174/157340308784245757.
36. Borlaug BA, Kane GC, Melenovsky V, Olson TP. Abnormal right ventricularpulmonary artery coupling with exercise in heart failure with preserved ejection fraction. Eur Heart J. 2016;37:3293-3302. doi: 10.1093/eurheartj/ehw241.
37. Abudiab MM, Redfield MM, Melenovsky V, Olson TP, Kass DA, Johnson BD, Borlaug BA. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail. 2013;15:776-785. doi: 10.1093/eurjhf/hft026.
38. Santos M, Opotowsky AR, Shah AM, Tracy J, Waxman AB, Systrom DM. Central cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension: implications for heart failure with preserved ejection fraction. Circ Heart Fail. 2015;8:278-285. doi: 10.1161/CIRCHEARTFAILURE.114.001551.
39. Dhakal BP, Malhotra R, Murphy RM, Pappagianopoulos PP, Baggish AL, Weiner RB, Houstis NE, Eisman AS, Hough SS, Lewis GD. Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction. Circ Heart Fail. 2015;8:286-294. doi: 10.1161/CIRCHEARTFAILURE.114.001825.
40. Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol. 2011;58:265-274. doi: 10.1016/j.jacc.2011.02.055.
41. Pandey A, Parashar A, Kumbhani DJ, Agarwal S, Garg J, Kitzman D, Levine BD, Drazner M, Berry JD. Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials. Circ Heart Fail. 2015;8:33-40. doi: 10.1161/CIRCHEARTFAILURE.114.001615.
42. Shah SJ, Kitzman DW, Borlaug BA, van Heerebeek L, Zile MR, Kass DA, Paulus WJ. Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation. 2016;134:73-90. doi: 10.1161/CIRCULATIONAHA.116.021884.
43. Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, Redfield MM. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2010;56:845-854. doi: 10.1016/j.jacc.2010.03.077.